JNJ vs VRTX
By Alex · Tickerpine
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | VRTX |
|---|---|---|
| Price | $285.75 | $538.60 |
| Market cap | $687.89B | $136.56B |
| P/E ratio | 43.4 | 34.7 |
| ROE | 20.02% | 20.80% |
| Profit margin | 16.20% | 30.70% |
| Revenue growth | 5.90% | 11.80% |
| Dividend yield | 1.88% | 0.00% |
| Beta | 0.20 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs VRTX in plain English
- JNJ is the bigger company — about 5.0× the market cap of VRTX.
- VRTX is cheaper on earnings (P/E 34.7 vs 43.4).
- VRTX earns a higher return on equity (21% vs 20%).
- VRTX is growing revenue faster (12% vs 6%).
- JNJ pays a dividend (1.88%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.